Gregorio Maranon University Hospital | Spain

Author Profile

EARLY ACADEMIC PURSUITS

Since 2017, I have been dedicated to advancing the field of pharmacogenetics, beginning as a research assistant and progressing through to postdoctoral researcher at the Pharmacogenetics Laboratory of the Gregorio Marañón General University Hospital. My journey started with foundational research roles and evolved into leadership positions within various pharmacogenomic studies.

PROFESSIONAL ENDEAVORS

Starting as a research assistant, I gradually transitioned to roles as a predoctoral and postdoctoral researcher, accumulating invaluable experience and expertise in pharmacogenetics. My work has been primarily focused on pharmacogenomic studies in diverse medical areas such as colorectal cancer, multiple sclerosis, psychiatry, and intestinal inflammatory diseases.

CONTRIBUTIONS AND RESEARCH FOCUS ON PHARMACOGENMICS AND PERSONALIZED MEDICINE

Throughout my career, I have actively contributed to 21 publications in pharmacogenomics, with a particular emphasis on colorectal cancer, multiple sclerosis, psychiatry, and intestinal inflammatory diseases. Of these publications, I served as the first author for 14, showcasing my significant contributions to the field. Notably, my doctoral thesis in 2020 centered on intestinal inflammatory disease, underscoring my commitment to advancing knowledge in this area.

IMPACT AND INFLUENCE

My contributions have not gone unnoticed, as evidenced by receiving the AEFA (Spanish Clinical Laboratory Association) award for quality and innovation in 2019. Additionally, my research has been recognized through presentations at 20 national and international conferences, including 5 oral communications. I have been honored with the best oral communication award at three conferences, highlighting the impact of my work.

ACADEMIC CITES

My research has contributed to the academic discourse, with citations in various publications, further validating the significance and influence of my work in pharmacogenetics awards and related fields.

LEGACY AND FUTURE CONTRIBUTIONS

As an active member of the Spanish Society of Pharmacogenetics awards and the Spanish Association of Human Genetics, I continue to contribute to the advancement and dissemination of knowledge in these critical areas of public health. My ongoing commitment to research and collaboration ensures that my contributions will continue to shape the future of pharmacogenetics.

NOTABLE PUBLICATIONS

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children 2023(3)

Single nucleotide polymorphisms in ADAM17, IL23R and SLCO1C1 genes protect against infliximab failure in adults with Crohn's disease 2023(7)

Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort 2023(7)

Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain 2022(5)

Pharmacogenetics to avoid adverse reactions in cardiology: Ready for implementation? 2021(4)

Jian Luo | Immunogenetics and Autoimmune Diseases | Best Researcher Award

Published on 13/04/202417/01/2025 by Genetics and Genomics

Dr. Jian Luo | Immunogenetics and Autoimmune Diseases | Best Researcher Award

University of Oxford | United Kingdom

Author Profile

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

Jian Luo embarked on his academic journey at West China School of Medicine, Sichuan University, where he completed his Bachelor of Science in Respiratory Care in 2012. His thirst for knowledge led him to pursue further studies, culminating in a Master of Medicine from the same institution in 2015.

PROFESSIONAL ENDEAVORS

Armed with a solid foundation in respiratory medicine, Jian Luo pursued a dual degree program, earning his M.D. and Ph.D. in Respiratory Medicine from West China School of Medicine, Sichuan University, China, in 2018. His academic pursuits then took him to the prestigious University of Oxford, where he completed a Joint DPhil in Respiratory Medicine Unit, NDM Experimental Medicine, in 2018.

CONTRIBUTIONS AND RESEARCH FOCUS ON IMMUNOGENETICS AND AUTOIMMUNE DISEASES

Throughout his career, Jian Luo has focused on advancing our understanding of respiratory diseases, particularly inflammatory airway diseases such as asthma and COPD, as well as respiratory critical care medicine, including acute respiratory distress syndrome (ARDS). His research efforts have delved into various aspects of immunology and clinical medicine, with notable investigations into the mechanisms of steroid resistance in various immune cells, the role of cytokines in eosinophil priming, and the immunological signatures of COVID-19 and Immunogenetics Award, particularly in relation to asthma.

IMPACT AND INFLUENCE

Jian Luo's contributions to the field of respiratory medicine are underscored by his extensive publication record, boasting over 25 peer-reviewed papers with an impressive cumulative impact factor of 406.36. Notably, his work has been recognized in high-impact journals such as Cell, Lancet Respiratory Medicine, and the Journal of Allergy and Clinical Immunology.

ACADEMIC CITATIONS

Jian Luo's research findings have garnered attention within the scientific community, evident in the numerous citations his work has received. His studies have contributed valuable insights into the pathogenesis and treatment of respiratory diseases, earning him recognition as a leading authority in the field.

LEGACY AND FUTURE CONTRIBUTIONS

As a senior immunologist and clinician, Jian Luo's legacy extends beyond his academic achievements to his mentorship of future generations of researchers and clinicians. His continued dedication to advancing respiratory medicine promises to shape the landscape of healthcare, paving the way for improved diagnostics, treatments, and ultimately, better outcomes for patients worldwide.

NOTABLE PUBLICATIONS

Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis 2022(103)

Awake prone positioning for patients with COVID-19-induced acute hypoxemic respiratory failure 2022(3)

IL-1β promotes IL-17A production of ILC3s to aggravate neutrophilic airway inflammation in mice 2023(2)

The use of high-flow nasal cannula in patients with chronic obstructive pulmonary disease under exacerbation and stable phases: A systematic review and meta-analysis 2023(4)

Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation 2023(1)

Maria Betania Melo De Oliveira | Environmental Monitoring | Best Researcher Award

Published on 30/03/202417/01/2025 by Genetics and Genomics

Prof Dr. Maria Betania Melo De Oliveira | Environmental Monitoring | Best Researcher Award

Federal University of Pernambuco | Brazil

AUTHOR PROFILE

scopus

EARLY ACADEMIC PURSUITS

Maria Betania Melo de Oliveira began her academic journey with a Bachelor's degree in Biological Sciences from the Federal Rural University of Pernambuco (UFRPE) from 1995 to 2000. Her thesis focused on the cytogenetic analysis of tomato cultivars, which laid the foundation for her future research endeavors. Continuing her academic pursuits, Maria Betania pursued a Master's degree in Plant Biology at the Federal University of Pernambuco (UFPE) from 2000 to 2002. Her thesis, under the guidance of Marcelo Guerra, involved the cytogenetic characterization of Lycopersicon esculentum cultivars and similar species, expanding her expertise in plant genetics and cytogenetics.

PROFESSIONAL ENDEAVORS

Maria Betania furthered her academic journey with a Ph.D. in Biological Sciences at UFPE from 2002 to 2006. Under the mentorship of Maria Alzira Paiva de Almeida, her research delved into the genetic diversity of Yersinia pestis strains, contributing significantly to the understanding of virulence, plasmid dynamics, and sequencing techniques in microbial genetics.

CONTRIBUTIONS AND RESEARCH FOCUS ON ENVIRONMENTAL MONITORING

Throughout her academic career, Maria Betania's research has primarily focused on molecular genetics and microorganism genetics. Her work has contributed to understanding the genetic mechanisms underlying virulence in pathogens like Yersinia pestis and the cytogenetic characteristics of plant species, particularly tomatoes. Her expertise spans techniques such as VNTR analysis, sequencing, in situ hybridization, and fluorochrome staining.

IMPACT AND INFLUENCE

Maria Betania's contributions have left a notable impact on the fields of genetics and microbiology. Her research findings have been instrumental in advancing knowledge in microbial pathogenesis and plant genetics. Through her mentorship and collaborations, she has influenced the next generation of researchers and contributed to interdisciplinary studies bridging the gap between plant and microbial biology.

ACADEMIC CITATIONS

Her work has been cited extensively in the academic community, indicating its relevance and impact on the scientific community. Researchers have referenced her studies on genetic diversity in Yersinia pestis strains and cytogenetic characterization of plant species in their own investigations, further amplifying her influence in the field.

LEGACY AND FUTURE CONTRIBUTIONS

Maria Betania's legacy lies in her significant contributions to the fields of genetics and microbiology, evident through her extensive publication record and academic citations. Her future contributions are anticipated to further deepen our understanding of microbial pathogenesis and plant genetics, paving the way for innovative solutions in agriculture and medicine.

NOTABLE PUBLICATIONS

Antinociceptive and anti-inflammatory activities of essential oil of the leaves of Amburana cearensis (Allemão) A.C. Smith. from the semi-arid region of Northeastern Brazil 2023(1)

Genetic and Biochemical Diversity of Clinical Acinetobacter baumannii and Pseudomonas aeruginosa Isolates in a Public Hospital in Brazil 2021(3)

Molecular characterization and evaluation of virulence traits of Aeromonas spp. isolated from the tambaqui fish (Colossoma macropomum) 2020(29)

Effects of Cefazolin and Meropenem in Eradication Biofilms of Clinical and Environmental Isolates of Proteus mirabilis 2020(3)

Antifungal activity of terpenes isolated from the Brazilian Caatinga: a review | Atividade antifúngica de terpenos isolados da caatinga: uma revisão

Bijina Balakrishnan | Molecular Basis of Genetic Disease | Best Researcher Award

Published on 30/03/202417/01/2025 by Genetics and Genomics

Dr. Bijina Balakrishnan | Molecular Basis of Genetic Disease | Best Researcher Award

University of Utah | United States

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Bijina Balakrishnan embarked on her academic journey in the field of biotechnology with a Bachelor of Science degree in Biology & Chemistry from the University of Calicut, Kerala, India, in 1999. She further pursued her passion for biotechnology by obtaining a Master of Science degree in Biotechnology from Cochin University of Science and Technology, Kerala, India, in 2002. Her dedication to advancing knowledge in the field led her to pursue a Doctor of Philosophy (PhD) in Biotechnology, which she successfully completed at Cochin University of Science and Technology, Kerala, India, in 2008.

PROFESSIONAL ENDEAVORS

Balakrishnan's professional journey has been characterized by a steadfast commitment to research excellence and innovation. She has held various significant positions in esteemed academic and research institutions, including:

RESEARCH SCIENTIST University of Utah, Salt Lake City (2021 - Present)

RESEARCH ASSOCIATE University of Utah, Salt Lake City (2019 - 2021)

POST-DOCTORAL FELLOW University of Utah, Salt Lake City (2014 - 2019)

POST-DOCTORAL FELLOW Nanyang Technological University, Singapore (2008)

SENIOR RESEARCH FELLOW Kannur University, India (2007 - 2008)

GRADUATE RESEARCHER Cochin University of Science and Technology, India (2003 - 2007)

CONTRIBUTIONS AND RESEARCH FOCUS ON MOLECULAR BASIS OF GENETICS DISEASE

Balakrishnan's contributions to the field of biotechnology are multifaceted and impactful, spanning from basic research to translational applications. Her research endeavors have primarily focused on rare metabolic disorders, with a particular emphasis on Galactosemia and dilated cardiomyopathy. Some notable contributions include:

Development and optimization of preclinical therapeutic interventions for Galactosemia and dilated cardiomyopathy.
Characterization of mouse models for Galactosemia and elucidation of disease mechanisms.
Design and execution of gene therapy strategies for cardiac-specific conditions.
Profiling small molecule modulators for novel therapeutic targets.
Investigation of cellular responses to viral proteins, such as the SARS-CoV-2 Spike protein, and evaluation of potential therapeutic interventions.

IMPACT AND INFLUENCE

Balakrishnan's work has made a significant impact on both the scientific community and the broader field of biotechnology. Her research findings have been presented at numerous conferences and workshops, contributing to the dissemination of knowledge and fostering collaboration among scientists. Additionally, her efforts have led to the development of novel therapeutic approaches for rare metabolic disorders, offering hope to patients and clinicians alike.

ACADEMIC CITATIONS

Balakrishnan's research contributions have been recognized through academic honors and awards, including the Best Researcher Award at the International Research Awards on Cardiology and Cardiovascular Medicine. Moreover, she has received prestigious grants and funding support from organizations such as the Galactosemia Foundation and the National Institutes of Health (NIH).

LEGACY AND FUTURE CONTRIBUTIONS

Balakrishnan's legacy in the field of biotechnology is characterized by her dedication to scientific inquiry, innovation, and translational research. As she continues her professional journey, she remains committed to advancing knowledge, developing novel therapeutic interventions, and mentoring the next generation of scientists. Her future contributions are poised to further shape the landscape of biotechnology and positively impact the lives of individuals affected by rare metabolic disorders.

NOTABLE PUBLICATIONS

Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia 2020(38)

Structure-Based Optimization of Small Molecule Human Galactokinase Inhibitors 2021(3)

AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG) 2023(3)

AAV9-based PMM2 gene replacement augments PMM2 expression and improves glycosylation in primary fibroblasts of patients with phosphomannomutase 2 deficiency (PMM2-CDG)

Whole-body galactose oxidation as a robust functional assay to assess the efficacy of gene-based therapies in a mouse model of Galactosemia

Nairy Khodabakhshian | Cardiovascular Genetics and Genomics | Best Researcher Awards

Published on 21/03/202417/01/2025 by Genetics and Genomics

Ms. Nairy Khodabakhshian | Cardiovascular Genetics and Genomics | Best Researcher Awards

University of Toronto | Canada

Author Profile

Orcid ID

EARLY ACADEMIC PURSUITS:

Nairy Khodabakhshian commenced her academic journey with a Bachelor of Science (Honors) in Biomedical Science from the Department of Chemistry and Biology at Toronto Metropolitan University, where she delved into research under the supervision of Dr. Costin Antonescu. Her focus revolved around investigating the Role of Clathrin in Akt Isoform Phosphorylation.

PROFESSIONAL ENDEAVORS:

Transitioning into her doctoral studies, Nairy Khodabakhshian pursued a PhD in the Institute of Medical Science at the University of Toronto under the guidance of Dr. Luc Mertens, with Dr. Vitor Guerra serving as her co-supervisor. Her doctoral research centers on exploring Vascular and Ventricular Responses to Exercise in Pediatric Connective Tissue Disorder Patients, with a specific emphasis on Marfan Syndrome and Loeys-Dietz Syndrome.

CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR GENETICS AND GENOMICS :

Khodabakhshian's contributions to academia extend beyond her research. She has actively engaged in various committees and advisory roles, such as the SickKids Cardiology Advisory Committee, showcasing her commitment to advancing medical science and patient care. Furthermore, her research endeavors have been supported by prestigious awards and grants, including the Graduate Education Innovation Fund, Queen Elizabeth II-GSST/Heart & Stroke Foundation Graduate Scholarships, and the Loeys-Dietz Syndrome Foundation Canada: LEAP Impact Award.

IMPACT AND INFLUENCE:

Khodabakhshian's impactful work has been recognized through numerous accolades, including the Student IMPACT Award and the Healthcare Innovation Challenge awards. These acknowledgments highlight her dedication to pushing the boundaries of medical research and innovation, contributing to the broader scientific community.

ACADEMIC CITATIONS:

While specific citation metrics are not provided, Khodabakhshian's research likely contributes to the academic discourse surrounding pediatric connective tissue disorders, cardiovascular health, and exercise physiology. Her publications and presentations likely garner attention within the scientific community, contributing to the advancement of knowledge in these fields.

LEGACY AND FUTURE CONTRIBUTIONS:

As Khodabakhshian continues her academic journey, her legacy will be shaped by her contributions to understanding vascular and ventricular responses in pediatric connective tissue disorder patients. Through her research, she not only aims to expand scientific knowledge but also to improve clinical practices and ultimately enhance patient outcomes. Her future contributions hold promise for further advancements in the diagnosis, treatment, and management of cardiovascular conditions in pediatric populations.

NOTABLE PUBLICATIONS:

Virtual Reality for Developing Patient-Facing Communication Skills in Medical and Graduate Education: Protocol for a Scoping Review 2024

Impact of Genotype-Phenotype Interactions on Cardiovascular Function in Paediatric Loeys-Dietz Syndrome 2023

Xiao Lin | Molecular Basis of Genetic Disease | Best Researcher Award

Published on 20/03/202417/01/2025 by Genetics and Genomics

Dr. Xiao Lin | Molecular Basis of Genetic Disease | Best Researcher Award

Capital Medical University | China

AUTHOR PROFILE

Orcid ID

EARLY ACADEMIC PURSUITS

Xiao Lin's academic journey began at Qingdao University, where she pursued a Bachelor of Clinical Medicine from 2012 to 2017. This foundational education provided her with a solid understanding of clinical medicine, setting the stage for her future specialization in ophthalmology. Moving forward, Lin pursued a Master of Medicine in Ophthalmology at Tianjin Medical University Eye Hospital from 2017 to 2020. During this time, she delved deeper into the intricacies of eye health, honing her skills and knowledge in this specialized field. Lin's commitment to academic excellence led her to further her studies at Capital Medical University in Beijing.

PROFESSIONAL ENDEAVORS

Throughout her academic journey, Xiao Lin has actively engaged in various professional endeavors aimed at advancing ophthalmology research and practice. During her time at Tianjin Medical University Eye Hospital, Lin focused on the application of optogenetic techniques in the treatment of uveal melanoma. This research not only demonstrated her dedication to exploring innovative treatment modalities but also showcased her ability to apply cutting-edge technologies to address clinical challenges in ophthalmology. Currently, Lin is part of the 502 Laboratory at Beijing Institute of Ophthalmology, where she is focusing on exploring the molecular mechanism of RHO mutation based on patient-derived retinal organoids.

CONTRIBUTIONS AND RESEARCH FOCUS ON MOLECULAR BASIS OF GENETIC DISEASE

Lin's research contributions span various aspects of ophthalmology, from investigating novel treatment modalities to unraveling the molecular mechanisms underlying retinal diseases. Her work at Tianjin Medical University Eye Hospital laid the groundwork for the application of optogenetic techniques in the treatment of uveal melanoma. By leveraging the principles of optogenetics, Lin sought to develop innovative strategies for targeted therapy, potentially revolutionizing the management of this challenging ocular condition. Currently, Lin's research at Capital Medical University focuses on elucidating the molecular mechanisms of RHO mutation using patient-derived retinal organoids.

IMPACT AND INFLUENCE

Lin's research endeavors have the potential to have a significant impact on the field of ophthalmology, both in terms of advancing scientific knowledge and improving patient outcomes. Her pioneering work on optogenetic techniques for uveal melanoma treatment has garnered attention within the ophthalmic community, offering new perspectives on the management of this challenging condition. By exploring innovative approaches to therapy, Lin's research has the potential to transform the landscape of ocular oncology, providing hope for patients facing this devastating disease.

ACADEMIC CITATIONS

Lin's contributions to ophthalmology research have been recognized through academic citations in scholarly publications and presentations. Her work on optogenetic techniques for uveal melanoma treatment has been cited in several peer-reviewed journals and conference proceedings, highlighting the significance of her findings within the scientific community. Additionally, Lin's research on RHO mutation in retinal organoids is poised to make a substantial impact in the field, with the potential for further citations and collaborations as the work progresses.

LEGACY AND FUTURE CONTRIBUTIONS

As Xiao Lin continues to advance in her academic and professional pursuits, her legacy in the field of ophthalmology is sure to endure. Her dedication to pushing the boundaries of knowledge and innovation in eye health positions her as a leader in the field, with the potential to shape the future of ophthalmic research and clinical practice. Through her ongoing contributions to understanding retinal diseases and developing novel therapeutic strategies, Lin is poised to leave a lasting impact on the field, improving the lives of countless individuals affected by vision impairment.

NOTABLE PUBLICATIONS

Modeling autosomal dominant retinitis pigmentosa by using patient-specific retinal organoids with a class-3 RHO mutation 2024

Blue light-triggered optogenetic system for treating uveal melanoma 2020(18)

Chunsik Shim | Genetics and Genomics of Disease | Best Researcher Award

Published on 19/03/202417/01/2025 by Genetics and Genomics

Prof Chunsik Shim | Genetics and Genomics of Disease | Best Researcher Award

Mokpo National University | South Korea

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Shim Chun-Sik embarked on his academic journey by obtaining a Bachelor of Science in Naval Architecture and Ocean Engineering from Inha University, Korea, in 1995. This laid the foundation for his subsequent academic and professional achievements.

PROFESSIONAL ENDEAVORS

Shim's career trajectory included significant roles in academia and industry. Notably, he served as a Chief Engineer at Daewoo Shipbuilding and Marine Engineering Co., LTD. from 2003 to 2006, contributing to the practical aspects of shipbuilding and marine engineering. His tenure as a Research Scholar at Washington State University Vancouver from 2011 to 2013 broadened his international exposure and collaboration.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENETICS AND GENOMICS OF DISEASE

Shim Chun-Sik's contributions spanned a wide array of research domains, primarily focusing on fatigue testing, material evaluation, and structural analysis. Noteworthy projects include the assessment of low-temperature strength for 3.5% Nickel Steel and the study of structural characteristics of tower flange connections in offshore wind turbine systems. His research endeavors significantly advanced the understanding and practical applications of materials and structures in marine and offshore environments.

IMPACT AND INFLUENCE

Shim's work has had a substantial impact on the field of naval architecture and marine engineering, particularly in the areas of fatigue testing, material characterization, and structural analysis. His research outcomes have informed industry practices, contributing to the development of safer and more efficient marine and offshore structures.

ACADEMIC CITATIONS

Shim Chun-Sik's scholarly contributions have garnered recognition and citations within the academic community. His publications in reputable journals and presentations at international conferences have enriched the body of knowledge in naval architecture and marine engineering.

LEGACY AND FUTURE CONTRIBUTIONS

As a Director at the SURF R&D Center of Mokpo National University and a Professor in the Department of Naval Architecture & Marine Engineering, Shim continues to inspire and mentor the next generation of researchers and engineers. His legacy lies in his dedication to advancing the field through rigorous research, industry collaboration, and academic leadership. In the future, Shim's contributions are expected to further propel innovation and excellence in naval architecture and marine engineering.

HIGHLIGHTS

Diverse expertise in fatigue testing, material evaluation, and structural analysis.
Extensive professional experience in both academia and industry.
Significant contributions to advancing knowledge and practice in naval architecture and marine engineering.
Ongoing commitment to mentoring and fostering academic and industrial collaboration.

Notable Publications

Bearing strength of interference-fit pin joined glass fiber reinforced plastic composites 2020

Structural Safety Assessment of Lift Apparatus on Jack-Up Barge for Eco-Friendly Offshore Installation 2021

Bearing strength of interference-fit pin joined glass fiber reinforced plastic composites 2020(16)

Integrated simulation framework for offshore installation operations considering various ocean environment 2018(3)

Dynamic analysis of offshore structure installation operation using dual floating cranes based on multibody system dynamics 2016(3)

Hongsheng Dai | Pharmacogneomics and Personalized medicine | Best Researcher Award

Published on 19/03/202417/01/2025 by Genetics and Genomics

Prof Hongsheng Dai | Pharmacogneomics and personalized medicine | Best Researcher Award

Newcastle University | United Kingdom

Author Profile

Scopus

Orcid ID

Google Scholar

Early Academic Pursuits

Hongsheng Dai pursued his academic journey with a B.Sc. in Applied Mathematics from Tianjin University, followed by an M.Sc. in Statistics from Beijing University, where he focused on survival analysis. He furthered his studies with a D.Phil. in Statistics from the University of Oxford, specializing in perfect Monte Carlo simulation techniques.

Professional Endeavors

Dai's professional journey showcases a progression from lecturer roles to professorships, demonstrating his dedication and expertise in the field of statistics. He held positions at various prestigious institutions, including Lancaster University, Brighton University, and the University of Essex, before assuming his current role as a Professor in Statistics at Newcastle University.

Contributions and Research Focus on Pharmacogenomics and personalized medicine

Dai's research interests encompass a broad spectrum of statistical methodologies, including exact Monte Carlo simulations, Bayesian computational methods, graphical models, mixture models, and survival analysis. His notable contributions include advancements in coupling from the past, path-space rejection sampling, Bayesian fusion, and nonparametric survival analysis for both censored and truncated bivariate data.

Impact and Influence

Dai's research has garnered significant recognition, as evidenced by the grants he has secured, such as the ERC Synergy Grant and EPSRC funding. His work on responsible AI for gender and ethnic labor market equality reflects his commitment to addressing societal challenges through statistical methodologies.

Academic Citations

Dai's work has likely garnered citations in various academic publications, particularly in the fields of statistics, computational methods, and applied mathematics, given the breadth and depth of his research contributions.

Legacy and Future Contributions

Dai's legacy lies in his substantial contributions to statistical methodologies, particularly in exact Monte Carlo simulations and survival analysis. His interdisciplinary collaborations and innovative approaches have positioned him as a leader in the field. Looking forward, Dai is poised to continue making significant contributions to statistical research, with potential applications in diverse domains.

Notable Publications

Balancing Gender Bias in Job Advertisements With Text-Level Bias Mitigation 2022(7)

The role of insulators and transcription in 3D chromatin organization of flies 2022(18)

Word Embeddings via Causal Inference: Gender Bias Reducing and Semantic Information Preserving 2022(15)

ZipHiC: a novel Bayesian framework to identify enriched interactions and experimental biases in Hi-C data 2022(4)

Efficient empirical likelihood inference for recovery rate of COVID19 under double-censoring 2022 (1)

Yuan MA | Gene Therapy Award | Young Scientist Award

Published on 07/03/202417/01/2025 by Genetics and Genomics

Dr. Yuan MA | Gene Therapy Award | Young Scientist Award

Hong Kong Baptist University | China

AUTHOR PROFILE

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

Dr. Yuan Ma embarked on an academic journey marked by excellence and dedication. Graduating with a Bachelor's degree in Medical Chemistry from Peking University in 2013, he continued his studies at the same institution, earning a Master's degree in Medical Chemistry in 2015. His academic prowess culminated in a Ph.D. in Medical Science from Peking University's School of Medicine in 2019. These formative years laid the foundation for his subsequent professional endeavors and contributions to the field.

PROFESSIONAL ENDEAVORS

Dr. Ma's professional trajectory reflects a commitment to advancing medical science and translational research. Following the completion of his Ph.D., he embarked on a postdoctoral research fellowship at the Institute for Advancing Translational Medicine in Bone & Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University. This role provided him with valuable insights into translational research methodologies and interdisciplinary collaboration. Subsequently, he served as an Associate Research Fellow at Mengchao Hepatobiliary Hospital of Fujian Medical University, contributing to the exploration of innovative medical interventions.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENE THERAPY AWARD

Throughout his academic and professional journey, Dr. Ma has focused his research efforts on areas of critical importance in medical science. His expertise encompasses nucleic acid drug discovery, precision medicine, and innovative drug development. His contributions have significantly advanced our understanding of aptamer-based translational medicine and drug discovery, particularly within the context of hepatobiliary diseases. Dr. Ma's research stands at the forefront of addressing pressing healthcare challenges, offering novel therapeutic avenues for improving patient outcomes.

IMPACT AND INFLUENCE

Dr. Ma's work has garnered recognition within the academic community and beyond, underscoring his impact and influence in the field of medical science. As the General Secretary of the Hong Kong Pharmaceutical Academy, he plays a pivotal role in shaping the future of pharmaceutical research and education. His membership in esteemed organizations such as the HKBU and IncreasePharm Joint Centre for Nucleic Acid Drug Discovery, Institute for Precision Medicine and Innovative Drug, and Guangdong-Hong Kong-Macao Greater Bay Area International Research Platform for Aptamer-based Translational Medicine and Drug Discovery underscores his standing as a thought leader in his field.

ACADEMIC CITATIONS

Dr. Ma's research findings have been disseminated widely, garnering citations from peers and scholars globally. His publications in reputable journals serve as a testament to the significance of his work and its contribution to advancing medical science. Through rigorous inquiry and meticulous experimentation, Dr. Ma has expanded the frontiers of knowledge in his domain, earning the respect and recognition of his peers.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Ma's legacy is characterized by a tireless pursuit of scientific excellence and a commitment to improving human health. His research endeavors have laid the groundwork for future breakthroughs in nucleic acid drug discovery and translational medicine. As he continues to chart new territories and push the boundaries of scientific inquiry, Dr. Ma remains dedicated to his mission of translating research findings into tangible therapeutic solutions. His future contributions hold the promise of transformative impact, further solidifying his position as a trailblazer in the field of medical science.

NOTABLE PUBLICATIONS

Nucleic acid amphiphiles: Synthesis, properties, and applications 2023(4)

Spatial imaging of glycoRNA in single cells with ARPLA 2023(10)

Chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding 2023(11)

Binding Affinity Measurements Between DNA Aptamers and their Virus Targets Using ELONA and MST 2022(2)

Strategies for developing long-lasting therapeutic nucleic acid aptamer targeting circulating protein: The present and the future 2022(9)

Ebru Dundar-Yenilmez | Neurogenetics and Neuropsychiatric Disorders | Best Researcher Award

Published on 26/02/202417/01/2025 by Genetics and Genomics

Prof Dr. Ebru Dundar-Yenilmez | Neurogenetics and Neuropsychiatric Disorders | Best Researcher Award

Cukurova University | Turkey

AUTHOR PROFILE

Scopus

Orcid ID

Google Scholar

EARLY ACADEMIC PURSUITS

Ebru Dündar Yenilmez began her academic journey with a Bachelor's degree in Biology from Çukurova University's Faculty of Science and Literature. This foundational education laid the groundwork for her future pursuits in biochemistry and genetics. She continued her studies at the same university, undertaking a Master's degree followed by a PhD in Biochemistry from the Institute of Health Science. These early academic pursuits provided her with a comprehensive understanding of biological systems, paving the way for her specialization in molecular biochemistry, epigenetics, and pharmacogenetics.

PROFESSIONAL ENDEAVORS

Following the completion of her PhD, Ebru Dündar Yenilmez embarked on a career as a research assistant at Çukurova University's Faculty of Medicine, Department of Medical Biochemistry. Over the years, she demonstrated excellence in research and teaching, leading to her appointment as a lecturer upon obtaining her doctorate. Her dedication to academia and her field is evident in her commitment to teaching medical biochemistry at both the Medicine and Dentistry faculties.

CONTRIBUTIONS AND RESEARCH FOCUS ON NEUROGENETICS AND NEUROPSYCHIATRIC DISORDERS

Ebru Dündar Yenilmez has made significant contributions to the fields of molecular biochemistry, epigenetics, pharmacogenetics, and molecular diagnostics techniques. Her research endeavors have focused on understanding the molecular basis of hereditary diseases, with a particular emphasis on the role of DNA and RNA in disease pathogenesis. Through her work, she has advanced our understanding of complex biological processes and paved the way for the development of novel diagnostic and therapeutic approaches.

IMPACT AND INFLUENCE

As a member of esteemed organizations such as the European Society of Human Genetics, Turkish Society of Biochemistry, and European Society Pharmacogenomics and Personalized Therapy, Ebru Dündar Yenilmez has actively contributed to the global scientific community. Her research findings have been disseminated through publications in prestigious journals and presentations at international conferences, amplifying her impact and influence within her field.

ACADEMIC CITATIONS

Ebru Dündar Yenilmez's contributions to academia are reflected in her citation record, with her research being cited by peers and scholars across the globe. Her work serves as a cornerstone for further research and exploration in molecular biochemistry and related disciplines, further solidifying her position as a respected authority in her field.

LEGACY AND FUTURE CONTRIBUTIONS

Ebru Dündar Yenilmez's legacy extends beyond her individual accomplishments, encompassing the students she has mentored and the knowledge she has imparted. As she continues her academic journey, she remains dedicated to pushing the boundaries of scientific understanding and fostering the next generation of researchers. Her future contributions hold the promise of further unraveling the complexities of molecular biology and advancing personalized medicine for the benefit of society.

NOTABLE PUBLICATIONS

Cord Blood Hematological Parameters of Fetuses Detected Different Thalassemia Genotypes in the Second Trimester of Pregnancy 2023 (2)

The effect of Vitamin D on testosterone and uncarboxylated osteocalcin levels in aged male rats 2022

Investigation of beta globin gene mutations in Syrian refugee patients with thalassemia major 2019(2)

Beneficial effects of rolipram, a phosphodiesterase 4 specific inhibitor, on testicular torsion-detorsion injury in rats 2018(16)

A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women 2018(11)